Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05877391 · ClinicalTrials.gov registry record · NA
Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice
A NA study of Alzheimer's Disease and Related Dementias and Hospice, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05877391 is a NA study of Alzheimer's Disease and Related Dementias and Hospice that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 80 participants, below the 1,623-participant average among 5 other Alzheimer's Disease and Related Dementias trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05877391, a NA study of Alzheimer's Disease and Related Dementias and Hospice, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Older sexual and gender minority (SGM) patients are at risk for receiving inequitable end-of-life care; those with Alzheimer's disease and related dementias (ADRD) are at particularly high risk. Failure to collect and integrate sexual orientation and gender identity (SOGI) data to identify patients' informal support systems may have adverse health consequences for SGM older adults, particularly for those dependent on informal caregivers to provide in-home support and assist with activities of daily living. The goal of this K01 is develop a novel training for hospice staff in person-centered communication that includes SOGI data collection to promote authentic end-of-life care for SGM patients and their caregivers.
Conditions Studied
Interventions
- BEHAVIORAL SGM Communication Intervention
Study Locations (1)
Colorado
- University of Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-03-13 |
| Est. Completion | 2027-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05877391
The ClinicalTrials.gov registry entry for NCT05877391 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,623-participant average among 5 other Alzheimer's Disease and Related Dementias trials with a reported enrollment target (95% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Alzheimer's Disease and Related Dementias appearing as the primary indexed condition, and to 1 intervention - of which SGM Communication Intervention is the first listed.
NCT05877391 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT05877391 about?
NCT05877391 is a clinical study titled "Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice". Older sexual and gender minority (SGM) patients are at risk for receiving inequitable end-of-life care; those with Alzheimer's disease and related dementias (ADRD) are at particularly high risk. Failure to collect and integrate sexual orientation and gender identity (SOGI) data to identify patients'...
What is the current status of trial NCT05877391?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-03-13. Estimated completion is 2027-09.
What conditions does trial NCT05877391 study?
This clinical trial studies the following conditions: Alzheimer's Disease and Related Dementias, Hospice, Sexual and Gender Minorities.
What interventions are being tested in trial NCT05877391?
The interventions under investigation include: SGM Communication Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05877391?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05877391 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer's Disease and Related Dementias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Translating Data Science to Palliative Care
COMPLETED · NA
-
Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2)
COMPLETED · NA
-
Smart Lighting for Nursing Home Residents With Dementia
COMPLETED · NA
-
OPTIMAL in NH Residents With Dementia
COMPLETED · NA
-
Preventing Alzheimer's With Cognitive Training
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.